Search results for: 'pace pharmaceutical'

The multi-parameter patient monitoring market is growing at a healthy double-digit pace in Asia-Pacific, largely due to several macro indicators such as increasing healthcare expenditures and a growing number of private hospitals. There is an increasing trend in Southeast Asia towards the use of networked patient monitors using Wi-Fi and other netw...

03 Sep 2015  |  Global  |  Market Research

Global Big Data and Cloud Analytics Test Services Market

Self-Organizing Networks, Cloud-Based Radio Access Networks, and Internet of Things to Drive the Market

Infographics

×

Due to the unprecedented rise in digital information, network operators are challenged with finding ways to address network utilization more efficiently. In a bid to curb capital investments and operating expenditures, cloud computing is being adopted at a higher pace than ever before. As software-defined networks (SDN) and network function virtual...

Global smart grid investment is likely to grow rapidly. By 2025, a complete transformation to a smarter grid is unlikely but the process would have gained pace with major changes underway in grid automation, demand-side management, and Big Data analytics. Revenue growth will be the fastest in Europe. Demand response and advanced metering infrastruc...

This research service analyses current and future trends in the Global active RFID and sensors market. Active RFID and RFID-based sensors are expected to gain greater traction in an emerging market. This service discusses various market drivers and restraints and also the challenges the market is facing right now and also gives an overview of vari...

The Infrastructure as a Service (IaaS) market remains highly active worldwide, having reached an astounding U$45.6 Billion in revenues in 2018. While adoption pace and patterns vary, all regions—North America, Europe, Latin America, and Asia-Pacific—are firmly on the path toward the cloud. In this report, we review key findings from the 2018 Clou...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

Respiratory diseases are related to the airways and the structures of the lungs. They can affect air sacs, interstitium, blood vessels, pleura, and chest wall. Common respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and occupational lung disease. According to the World Health Organization, m...

Rife geopolitical tensions and multiple external shocks during the past few years have been rapidly transforming global supply chains and pushing firms to take strategic site-selection decisions. The need for economic resiliency is fostering a paradigm shift as companies are directing investments into the establishment of local and regional manufac...